Jamison Private Wealth Management’s AbbVie ABBV Stock Holding History

Jamison Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.3M	Buy	60,804 +1,381	+2%	+$297K	1.54%	17
2026 Q1	$12.9M	Buy	59,423 +474	+0.8%	+$105K	1.57%	16
2025 Q4	$13.5M	Buy	58,949 +123	+0.2%	+$28K	1.64%	17
2025 Q3	$13.6M	Buy	58,826 +2,884	+5%	+$587K	1.73%	16
2025 Q2	$10.4M	Sell	55,942 -1,413	-2%	-$263K	1.49%	20
2025 Q1	$12M	Sell	57,355 -860	-1%	-$167K	1.83%	13
2024 Q4	$10.3M	Buy	58,215 +2,688	+5%	+$494K	1.53%	18
2024 Q3	$11M	Buy	55,527 +1,346	+2%	+$251K	1.67%	15
2024 Q2	$9.29M	Buy	54,181 +1,955	+4%	+$324K	1.54%	18
2024 Q1	$9.51M	Buy	52,226 +784	+2%	+$135K	1.61%	16
2023 Q4	$7.97M	Sell	51,442 -104	-0.2%	-$15.2K	1.49%	20
2023 Q3	$7.68M	Buy	+51,546	New	+$7.57M	1.59%	16

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jamison Private Wealth Management's ABBV Position: Q2 2026 in Review

Jamison Private Wealth Management increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $297K and bringing the position to 60,804 shares worth $15.3M. The position accounts for 1.54% of the portfolio, ranked #17.

Jamison Private Wealth Management first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Jamison Private Wealth Management held 60,804 shares of AbbVie worth $15.3M as of Q2 2026.
Jamison Private Wealth Management bought 1,381 AbbVie shares in Q2 2026, an estimated $297K.
AbbVie made up 1.54% of Jamison Private Wealth Management's portfolio in Q2 2026, its #17 holding.
Jamison Private Wealth Management first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jamison Private Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.